Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
181 studies found for:    cancer | Open Studies | wake forest
Show Display Options
Rank Status Study
1 Recruiting Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Other: biologic sample preservation procedure;   Other: medical chart review
2 Recruiting Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3
Condition: Stage IV Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Pemetrexed Disodium;   Other: Quality-of-Life Assessment
3 Recruiting Attitudes and Knowledge Regarding Clinical Trials in Underserved Populations Receiving Care at the Comprehensive Cancer Center of Wake Forest University
Condition: Malignant Neoplasm
Interventions: Other: Medical Chart Review;   Other: Questionnaire Administration;   Other: Survey Administration
4 Not yet recruiting Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations
Conditions: EGFR Activating Mutation;   Recurrent Non-Small Cell Lung Carcinoma;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Chemotherapy;   Biological: Immunotherapy;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Biological: Pembrolizumab;   Drug: Targeted Molecular Therapy;   Drug: Tyrosine Kinase Inhibitor
5 Recruiting Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery
Conditions: Advanced Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Unresectable Malignant Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Dietary Supplement: Muscadine Grape Skin Extract;   Procedure: Quality-of-Life Assessment
6 Not yet recruiting Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer
Conditions: Smoking;   Lung Neoplasms
Interventions: Other: Integrated Fitness Assessment;   Procedure: Psychosocial Assessment and Care;   Procedure: Quality-of-Life Assessment
7 Recruiting CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Conditions: Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Recurrent Colon Cancer;   Recurrent Rectal Cancer;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Stage IIIA Colon Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Rectal Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer
Interventions: Drug: 6,8-bis(benzylthio)octanoic acid;   Drug: fluorouracil;   Other: pharmacological study;   Other: laboratory biomarker analysis
8 Recruiting Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells
Conditions: Benign Prostatic Hyperplasia;   Prostate Carcinoma
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
9 Recruiting Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer
Condition: Breast Cancer
Intervention: Other: physiologic testing
10 Recruiting MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy
Conditions: Cardiac Toxicity;   Malignant Neoplasm
Intervention: Procedure: magnetic resonance imaging
11 Not yet recruiting Cardiovascular Injury, Exercise Intolerance and Fatigue After Adjuvant Chemotherapy for Stage I-III Breast Cancer
Condition: Breast Cancer
Interventions: Other: Observational;   Other: Data Collection;   Other: Assessments
12 Recruiting CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Intervention: Drug: 6,8-bis(benzylthio)octanoic acid
13 Recruiting Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Biological: Pembrolizumab;   Other: Quality-of-Life Assessment
14 Not yet recruiting MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment
Conditions: Healthy Subject;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Other: Cardiopulmonary Exercise Testing;   Procedure: Magnetic Resonance Imaging
15 Recruiting Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
Conditions: Metastatic Neoplasm;   Recurrent Neoplasm;   Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer;   Unresectable Malignant Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Targeted Therapy
16 Recruiting Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy
Conditions: Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Other: educational intervention;   Other: counseling intervention;   Behavioral: telephone-based intervention;   Other: questionnaire administration;   Procedure: quality-of-life assessment
17 Not yet recruiting Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Conditions: Human Papillomavirus Infection;   Stage I Oral Cavity Squamous Cell Carcinoma;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Biological: Durvalumab;   Other: Laboratory Biomarker Analysis;   Procedure: Therapeutic Conventional Surgery
18 Recruiting Reducing Lung Cancer Survivors' Anxiety and Dyspnea (RELAX)
Conditions: Lung Cancer;   Anxiety
Interventions: Device: Group A - Device guided breathing low dose;   Device: Group B - Device guided breathing high dose;   Device: Group C - Usual Breathing Control Group
19 Recruiting Community Hospital Identification of High CV Risk Patients During Cancer Treatment
Condition: Breast Cancer
Intervention: Other: Fast MRI and Questionnaires
20 Recruiting Improving Resection Rates Among African Americans With NSCLC
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Other: Usual Care;   Other: Intervention Arm

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.